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Abstract
Background: The Skull Base Inventory (SBI) was developed to assess the quality of life of patients undergoing
endoscopic or open approaches for anterior and central skull base pathologies. In this study, we sought to establish
the discriminative and evaluative properties for this instrument.
Methods: The SBI was administered in a cross-sectional fashion to patients who previously had skull base surgery
after treatment and then again 2 weeks after completing the instrument. Internal consistency, test-retest reliability,
and construct validity were determined. Four constructs were evaluated with the following a priori hypotheses:
lower scores will be seen in patients with 1.malignant versus benign histology, 2.a history of radiation versus none,
and those with 3.recurrences versus no recurrence, and 4.items deemed relevant versus irrelevant by respondents.
Results: Fifty-two patients completed the questionnaire; 32 had endoscopic and 20 open surgeries. Internal
consistency was good (>0.7 and <0.95) for all domains except one. Test-retest reliability was good (>0.70) for 38
of 41 items. Four constructs were evaluated and three were consistent with a priori hypotheses (p < 0.05). The
instrument failed to confirm the hypothesis that malignant tumours are associated with poorer scores than benign.
Conclusions: The SBI demonstrated preliminary reliability and validity for discriminative use.
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Background
Skull base tumours pose a significant challenge in surgi-
cal oncology due to their proximity to vital anatomical
structures [1]. In many instances, the primary manage-
ment of these tumours is surgical resection. Given the
challenging anatomical locations of such tumours,
patients may experience significant morbidity secondary
to the disease itself and/or the treatment [2–4]. With
recent improvements in endoscopic and open surgical
approaches, there has been an increasing interest in the
impact of tumours and surgical resection on patients’
health-related quality of life (QOL) [5]. QOL studies can
help inform health care providers of the functional
limitations that patients face, the obstacles to returning
back to their pre-illness health state, and the magnitude
of quality of life impairments by treatment approach.
To date, a number of QOL instruments for head and
neck cancers have been developed [2, 6–8]. Very few
have been designed to measure the QOL of patients with
anterior and central skull base pathologies. The existing
instruments are also limited in capturing the unique
morbidities that result from different tumour pathologies,
locations, and surgical approaches. The Skull Base Inven-
tory (SBI) was designed to overcome the limitations of
existing instruments [9].
The SBI is a multidimensional, disease-specific instru-
ment designed to measure QOL of patients who undergo
surgical treatment, regardless of surgical approach, for an-
terior or central skull base pathologies [9]. The instrument
has been designed using both expert and patient input to
be applicable to those who undergo open or endoscopic
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surgical approaches. The SBI was designed for both dis-
criminative and evaluative purposes, to capture the tem-
poral change in QOL, and to differentiate between the
QOL of different patient populations, which is of particu-
lar importance for assessing various surgical modalities. It
consists of 41 questions covering 11 disease-specific do-
mains including social, emotional, physical, cognitive, fam-
ily, financial, spiritual, endocrine, nasal, neurologic, and
visual. The comprehensive measurement properties of the
SBI however, have not yet been evaluated. The purpose of
the present study is to evaluate the psychometric proper-
ties of the SBI in a cross-sectional study. In specific, we
sought to determine the instrument’s reliability and valid-
ity in capturing disease-specific domain and overall QOL
of patients who have undergone skull base surgery.
Methods
Patient population
This study was granted approval by the University Health
Network’s Research Ethics Board. Informed consent was
obtained from all included patients.
All patients who were surgically treated for anterior or
central skull base pathologies between 1998 and 2008 at
the University Health Network were screened as poten-
tial participants for this study. Patients were included if
they had a minimum of 6 months from time of surgery,
were English speaking, currently alive, not lost to follow-
up, and were willing to consent to study participation.
Patients were contacted by telephone, interviewed over
the phone, and asked to complete the questionnaire by
interview. This study was executed in a cross-sectional
fashion with patients recruited between January and
June 2009.
Instrument administration and chart review
Included patients were asked to complete the 41 item
questionnaire by telephone and were subsequently asked
to complete the questionnaire again 14 days after their
initial completion in order to assess test-retest reliability.
Although there is no evidence for the optimum time
interval between test administration in test retest reli-
ability of health status instruments, we chose 14 days to
be long enough to minimize subject recall and carryover
effect, while having the time period short enough to
reduce the chance for change in health and/or mood
status [10]. In addition, patients were asked to rate the
relevance of each item on a seven point Likert scale to
their overall quality of life. The instrument scoring has
previously been described [9]. In brief, each domain is
scored out of 100 with lower scores associated with
poorer quality of life. Items within each domain for
which a response was recorded were summed and aver-
aged out of 100. A composite score assuming equivalent
weighting of domains in overall quality of life was created
by averaging domain scores. A retrospective chart review
was conducted for patients who consented to participate
in this study, and the following data were collected: pa-
tient factors (age, gender), disease factors (histopathology,
tumour location, stage) and type of adjuvant/neoadjuvant
therapies (radiotherapy, chemotherapy).
Statistical analysis
The consensus-based standards for the selection of
health measurement instruments (COSMIN) guidelines
for assessing the quality of studies on measurement prop-
erties of health measurement instruments was reviewed,
and the following statistical analyses were performed to
establish the discriminative and evaluative properties of
the SBI [11]. Internal consistency within domains was
assessed using Cronbach’s alpha. Internal consistency was
rated from unacceptable to acceptable as previously de-
scribed [12]. Item test-retest reliability was performed
using intra-class correlation (ICC). Correlation coefficients
of 0.7 or higher were considered good test-retest reliabil-
ity. Validity testing was performed using construct validity.
Four constructs with the following a priori hypotheses
were tested: (1) patients with malignant pathologies have
lower scores than those with benign pathologies (2)
patients with a history of radiation have lower scores
than those with no history of radiation, (3) patients with
tumour recurrence will have lower scores than those with
no recurrence, and (4) items deemed relevant by respon-
dents will be associated with lower scores than those
deemed irrelevant. All 41 questions were examined for
floor and ceiling effects; floor and ceiling effects were con-
sidered when more than 20 % of participants chose the
lowest or highest possible score, respectively. The minim-
ally important clinical difference (MCID) was determined
using distribution method (MCID = 0.5 standard devi-
ation) [13]. Probability (p) values ≤ 0.05 were considered
statistically significant. All statistical analyses were perfor-
med using IBM SPSS 20.0.
Results
Patient demographics
Fifty-two patients completed the 41-question SBI. Pa-
tient, disease, and treatment factors are described in
Table 1. The group of tumours consisted of both anter-
ior and central skull base locations. Tumour histopathol-
ogies varied considerably, and included adenocarcinoma
(5.8 %), adenoid cystic carcinoma (1.9 %), anterior skull
base/olfactory groove meningioma (3.8 %), planum or
tuberculum meningioma (5.8 %), cavernous hemangioma
(3.8 %), hemangioma (1.9 %), hemangiopericytoma (1.9 %),
chondrosarcoma (1.9 %), chordoma (17.3 %), craniophar-
yngioma (7.7 %), esthesioneuroblastoma (13.5 %), cortico-
tropic pituitary adenoma (13.5 %), somatotropic pituitary
adenoma (7.7 %), gonatotropic pituitary adenoma (1.9 %),
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lactotropic pituitary adenoma (3.8 %), juvenile nasopharyn-
geal angiofibroma (1.9 %), leiomyosarcoma (1.9 %), osteo-
sarcoma (1.9 %), and squamous cell carcinoma (1.9 %).
Reliability
Internal consistency of all domains of the SBI are pre-
sented in Table 2. The ‘other’ domain contains items
generally felt to be unrelated and comprised a type of
miscellaneous domain thus explaining the unacceptable
rating for internal consistency. The spiritual domain also
had an unacceptable rating for internal consistency.
Test-retest reliability for 38 out of 41 questions was
good (≥0.7). Three items had a test-retest reliability less
than 0.7, two of which were in the visual subdomain
(ICC = 0.66, 0.66) and one of which was in the social do-
main (ICC = 0.42).
Construct validity
Using the SBI, four constructs were evaluated (Table 3).
Three of the four constructs tested matched the a priori
hypotheses. Patients with a history of radiotherapy had a
worse overall QOL than those who did not receive
radiotherapy (73.3 vs 82.0, p = 0.04) with statistically
poorer QOL in family (79.0 vs 92.3, p = 0.03), financial
(75.3 vs 91.1, p = 0.03) social (76.5 vs 87.2, p = 0.05), and
nasal domains (54.5 vs 68.1, p = 0.05) (Fig. 1a). Patients
who had recurrent tumours also had worse overall QOL
than those who did not (70.0 vs 80.7, p = 0.03); with
lower domains scores in the emotional (63.2 vs 79.1, p =
0.05), family (73.9 vs 90.2, p = 0.02), social (73.2 vs 85.2,
p = 0.05), and neurologic (68.2 vs 80.4, p = 0.05) domains
(Fig. 1b). The fourth construct examined demonstrated
that items on the questionnaire that were deemed irrele-
vant by patients were associated with better scores than
those that were deemed relevant (p < 0.001) (Fig. 1c).
Contrary to the a priori hypothesis, patients with malig-
nant tumours did not have a statistically significant
difference in overall QOL compared to those with
Table 1 Demographics
Patient Factors
Average age (years) 46.4 ± 14.7
Gender
Male 24 (46.1 %)
Female 28 (53.8 %)
Disease Factors
Disease Status
Primary 41 (78.8 %)
Recurrent 11 (21.2 %)
Tumour Location
Anterior 22 (42.3 %)
Central 30 (57.7 %)
Benign vs. Malignant
Benign 27 (51.9 %)
Malignant 25 (48.1 %)
Treatment Factors
Surgical approach
Endoscopic 32 (61.5 %)
Open 20 (38.5 %)
Radiotherapy
Pre-op 17 (32.7 %)
Post-op 6 (11.5 %)
Chemotherapy
Pre-op 1 (1.9 %)
Post-op 2 (3.8 %)
Table 2 Internal consistency
Domain α (95 % CI) Rating
Cognitive 0.75 (0.60–0.85) Acceptable
Emotional 0.94 (0.90–0.96) Excellent
Family 0.85 (0.75–0.91) Good
Financial 0.80 (0.65–0.89) Good
Social 0.77 (0.62–0.86) Acceptable
Spiritual 0.33 (−0.23–0.63) Unacceptable
Endocrine 0.60 (0.38–0.75) Questionable
Nasal 0.71 (0.55–0.82) Acceptable
Neurologic 0.66 (0.49–0.79) Questionable
Visual 0.75 (0.62–0.85) Acceptable
Other 0.20 (−0.19–0.50) Unacceptable
All domains 0.87 (0.80–0.92) Good








Cognitive 0.83 0.43 0.24
Emotional 0.56 0.17 0.05a
Family 0.36 0.03a 0.02a
Financial 0.32 0.03a 0.09
Social 0.18 0.05a 0.05a
Spiritual 1.00 0.65 0.30
Endocrine 0.92 0.57 0.29
Nasal 0.06 0.05a 0.40
Neurologic 0.73 0.65 0.05a
Visual 0.37 0.18 0.35
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benign tumours (75.7 vs 80.3, p = 0.28) (Fig. 1d). The aver-
age time after surgery for completion of the SBI for those
with benign disease was 47.7 months versus 112.7 months
for those with malignant disease (p < 0.0001).
Floor and ceiling effects
No floor effects were observed for any of the items on
the SBI. Ceilings effects (>20 %) were observed in the
following 6 domains: emotional, family, financial, spirit-
ual, endocrine, and visual (Table 4). The financial and
family domains had ceiling responses in 56 % and 52 %
of respondents, respectively. The MCID was determined
to be 0.82.
Discussion
Measuring QOL in patients with skull base neoplasms is
challenging because of the variety of changes experienced
Fig. 1 Average SBI scores of different QOL domains for patients with and without radiotherapy (a), malignancy (b), and recurrent disease (d).
Average scores for items on the SBI deemed relevant versus irrelevant (c)
Table 4 Floor and ceiling effects
Domain Floor effect (% with
lowest possible score)
Ceiling effect (% with
highest possible score)
Cognitive No (0) No (14)
Emotional No (0) Yes (25)
Family No (0) Yes (52)
Financial No (2) Yes (56)
Social No (0) No (14)
Spiritual No (0) Yes (29)
Endocrine No (0) Yes (23)
Nasal No (0) No (6)
Neurologic No (0) No (14)
Visual No (0) Yes (23)
Other No (0) No (6)
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as a result of the pathology as well as the treatment. The
World Health Organization defines quality of life as ‘indi-
viduals’ perception of their position in life in the context
of their culture and value systems in which they live in
and in relation to their goals, expectations, standards, and
concerns [14]. It is a broad ranging concept affected in a
complex way by the person’s physical health, psychological
state, level of independence, social relationships, personal
beliefs, and their relationship to salient features of their
environment” [14]. In addition to affecting ones physical
functioning, treatment for skull base neoplasms affects
several other domains of life [9]. We designed an instru-
ment which purports to measure changes in QOL for pa-
tients with skull base neoplasms. Herein we present the
first psychometric assessment of the SBI and evaluation of
the measurement properties of this instrument. The study
incorporated responses from participants who had under-
gone skull base surgery at different time points with a
wide range of histopathologies, anatomic locations (anter-
ior and central skull base) and surgical approaches (endo-
scopic and open). Our results demonstrate that the SBI
has sound reliability and validity in capturing QOL in dis-
ease specific domains and overall QOL in patients who
undergo skull base surgery, regardless of when the instru-
ment was completed with respect to the operation. The
only domain that had an unacceptable rating for internal
consistency was the spiritual domain. In the SBI, there are
two questions within the spiritual domain: (1) In the past
2 weeks, has your condition made you question your reli-
gious beliefs? and (2) How would you rate your ability to
appreciate the small things in life. These two questions
may or may not be of the same measure and this highly
depends on one’s personal belief system, thoughts, opin-
ions, and perceptions of the world around them; therefore
explaining the lack of internal consistency observed within
this domain. In the present study, we did not have suffi-
cient sample size to perform factor analysis. In future
studies we will perform factor analysis to determine if
items load well onto each domain to confirm the items
belong in the proposed domains.
We tested construct validity through four a priori hy-
potheses. Three of these hypotheses were confirmed: (1)
patients with a history of radiation have a worse QOL,
(2) patients with primary cancer recurrence have a worse
QOL, and (3) questions on the SBI that have little rele-
vance to patients disease state are consistently scored
high. However, results obtained rejected our hypothesis
of patients with malignant tumours having worse QOL
than those with tumours of benign pathology. Failure to
verify this construct may be due either to the fact that
there indeed is no difference in QOL between patients
with malignant or benign tumours in our cohort, there
is a difference but the sample size was inadequate to
detect a difference, or there is a difference but the
instrument was not sensitive enough to detect this dif-
ference. The timing after surgery at which the question-
naire was completed may also explain the failure to
detect this difference. Previous studies have shown a dif-
ference in QOL between malignant and benign skull
base tumours at 6 months after surgery [15]. However,
the QOL impairment shortly after surgery, seems to
improve over time. In our cohort, patients completed
questionnaires generally much later after their surgery.
As such it may be that with time there is a norma-
lization of QOL that makes patients with benign and
malignant pathologies have similar QOL.
In the last two decades, anterior skull base surgery has
evolved rather rapidly owing to improved surgical tech-
niques [16, 17]. Advancements have led to reduced
mortality and morbidity. With the advent of endoscopic
approaches, comparisons have been made with open
approaches in terms of the extent of surgical resection,
survival, and now, QOL [15–17]. In general, most stud-
ies focusing on QOL have found that endoscopic
approaches allow for earlier improvements in QOL
following surgery [18, 19]. Nevertheless, open ap-
proaches continue to be necessary for tumours that are
not amenable to endoscopic resection and depending on
surgeon preference.
There are a number of challenges in measuring the
QOL of patients with skull base pathologies. Skull base
tumours are situated within the vicinity of vital neuro-
vascular structures that play significant roles in different
sensory organs and cognition. Endoscopic and open sur-
gical approaches also result in different post-operative
morbidities. We have shown that the symptom profiles
of different tumours vary considerably owing to variation
in size, morphology, location, pathology, and the surgical
technique used for resection [20]. Although it is ideal to
have different QOL instruments for different tumour
pathologies and locations, this is simply not feasible due
to the vast number of possible combination of tumours
types and locations. It is therefore important to have a
site-specific instrument that can accurately and holistic-
ally capture sensory, physical, and cognitive symptoms
following skull base surgery, and be applicable to both
endoscopic and open surgical approaches for different
tumour pathologies.
The Anterior Skull Base questionnaire (ASB) is an
existing instrument for measuring QOL after skull base
surgery. It is a validated and reliable tool that has six do-
mains [2, 21]. The ASB has been shown to be able to
predict postoperative QOL after skull base surgery [22].
However, the ASB was originally developed for open
skull base surgical patients. It consists of only seven
disease-specific items that may limit its discriminative
ability for different populations. In contrast, the SBI con-
sists of 26 disease specific items along with five physical
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subdomains and one cognitive domain that may increase
its discriminative ability; this must be tested in future
comparative studies.
Based on the COSMIN guidelines for assessing the
methodological quality of studies on measurements
properties of health status instrument, a comprehensive
instrument must consist of three domains: reliability,
validity, and responsiveness [10]. In this cross-sectional
study, we were limited in only assessing reliability and
validity since our study population comprised of patients
who had already undergone surgery and were measured in
a cross-sectional fashion. Additional multi-institutional
prospective studies are required to assess the responsive-
ness of the instrument by capturing the QOL of patients
before and after surgery, and evaluating the change in
QOL over time. Furthermore, a number of aspects of val-
idity were not evaluated, such as cross-cultural validity,
which is critical in QOL studies as perception of varying
health status’ can differ considerably for patients of differ-
ent socio-cultural backgrounds. Validating such properties
of the instrument require additional studies with different
patient populations and at different institutions.
Conclusion
Our preliminary data suggests that the SBI has sound
reliability and validity in assessing disease-specific and
overall QOL of patients who undergo skull base surgery
for anterior and central pathologies with both endo-
scopic and open surgical approaches. Additional studies
are needed to further validate the psychometric and
evaluative properties of the instrument in different pa-
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